KATHERINE TILLEM: Open Payments
NPI 1780239889 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 22 payments from 7 companies in 2025. Trend: 2023 $26 · 2024 $906 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $106 |
| ABBVIE INC. | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Madrigal Pharmaceuticals | 2 | $59 |
| Phathom Pharmaceuticals, Inc. | 6 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: TREMFYA, RINVOQ, DUPIXENT, REZDIFFRA, VOQUEZNA, ENTYVIO, XIFAXAN.
Industry payments across GA — which companies pay providers there.
